SCYNEXIS to Present at Upcoming H.C. Wainwright Global Investment Conference
JERSEY CITY, N.J., May 20, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to...
Month: May 2022
Dyadic to Present at H.C. Wainwright Global Investment Conference
JUPITER, Fla., May 20, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology...
Nanomix Receives CE Mark for its eLab COVID-19 Rapid Point-of-Care Antigen Panel
EMERYVILLE, Calif, May 20, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCBB: NNMX) (“Nanomix” or the “Company”), a leader in the...
PLx Pharma Inc. Showcases VAZALORE at The Annual Meeting of The Society for Cardiovascular Angiography and Interventions
VAZALORE Featured in Prominent Publication as Promising Alternative to Current Aspirin Options for Secondary Prevention of Cardiac EventsSPARTA, N. J.,...
ContraFect Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
YONKERS, N.Y., May 20, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX) (ContraFect), a late clinical-stage biotechnology company focused on...
ALR Technologies Announces Reincorporation Merger
SINGAPORE, May 20, 2022 (GLOBE NEWSWIRE) -- ALR Technologies Inc. (“ALRT USA”) (OTCQB: ALRT), the diabetes management company, today announces...
Immutep to Present at Investor Conferences
SYDNEY, AUSTRALIA, May 20, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology...
An organization of women volunteers raises $6 million for Shriners Hospitals for Children – Canada
MONTREAL, May 20, 2022 (GLOBE NEWSWIRE) -- The Daughters of the Nile is an international organization of women dedicated to...
Altimmune to Present Pemvidutide Clinical Data at Upcoming Global NASH Congress May 27, 2022
GAITHERSBURG, Md., May 20, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr....
Kymera Therapeutics Presented Preclinical Data Showcasing Impact of IRAK4 Degrader KT-474 on Immune and Skin Cells at the Society for Investigative Dermatology Annual Meeting
WATERTOWN, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein...
TG Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
Presentation available for on demand download beginning Tuesday May 24, 2022 at 7:00 AM ETNEW YORK, May 20, 2022 (GLOBE...
BridgeBio Pharma Affiliate Phoenix Tissue Repair Announces Positive Results from Phase 2 Trial of PTR-01, a Protein Replacement Therapy for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
- PTR-01 was well-tolerated over a four-month treatment period in RDEB patients - Treatment with PTR-01 led to rapid, consistent,...
Entourage Health Reaffirms First Quarter 2022 Preliminary Record Revenues of $17.4 Million and Announces Financial Results Call to be held on May 31, 2022
Q1 financial filings expected after-market May 30, with management conference call following dayTORONTO, May 20, 2022 (GLOBE NEWSWIRE) -- Entourage...
Anika Receives FDA 510(k) Clearance for the X-Twist™ Knotless Fixation System, Expanding its Sports Medicine Soft Tissue Portfolio
X-Twist provides a simple, versatile knotless suture anchor system ideal for key repairs in the shoulder, foot and ankle, and...
ASLAN Pharmaceuticals Presents Late-Breaking Poster on Eblasakimab and Neuronal Itch Mechanisms at the 2022 Society for Investigative Dermatology Annual Meeting
MENLO PARK, Calif. and SINGAPORE, May 20, 2022 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company...
BioXcel Therapeutics Announces Updated Presentation Time at H.C. Wainwright Global Investment Conference
NEW HAVEN, Conn., May 20, 2022 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a commercial-stage biopharmaceutical company utilizing artificial...
Immuneering Announces Participation in Upcoming Investor Conferences
CAMBRIDGE, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- Immuneering Corporation (NASDAQ: IMRX), a biopharmaceutical company using translational bioinformatics to advance...
Teleflex Hosts 2022 Analyst & Investor Day
WAYNE, Pa., May 20, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices, will...
Smart Immune Announces Oral Presentation of Cell-Fate Plasticity Data of its T-cell Progenitor-Based Therapy Platform (ProTcell™) at ASGCT 2022
Data demonstrates Smart Immune’s technology can be used to produce both therapeutic T-cell progenitors and NK cells with reproducibility and...
EsoCap supports first European EoE Day of the European Society of Eosinophilic Oesophagitis on May 22, 2022
Patients with eosinophilic esophagitis (EoE) suffer from severe symptoms including swallowing disorders, food impaction, vomiting, and heartburnEsoCap is currently conducting...